Modulating heterologous protein production in yeast: the applicability of truncated auxotrophic markers
- 782 Downloads
The use of auxotrophic Saccharomyces cerevisiae strains for improved production of a heterologous protein was examined. Two different marker genes were investigated, encoding key enzymes in the metabolic pathways for amino acid (LEU2) and pyrimidine (URA3) biosynthesis, respectively. Expression plasmids, carrying the partly defective selection markers LEU2d and URA3d, were constructed. Two CEN.PK-derived strains were chosen and insulin analogue precursor was selected as a model protein. Different truncations of the LEU2 and URA3 promoters were used as the mean to titrate the plasmid copy number and thus the recombinant gene dosage in order to improve insulin productivity. Experiments were initially carried out in batch mode to examine the stability of yeast transformants and to select high yielding mutants. Next, chemostat cultivations were run at high cell density to address industrial applicability and long-term expression stability of the transformants. We found that the choice of auxotrophic marker is crucial for developing a yeast expression system with stable heterologous protein production. The incremental truncation of the URA3 promoter led to higher plasmid copy numbers and IAP yields, whereas the truncation of the LEU2 promoter caused low plasmid stability. We show that the modification of the level of the recombinant gene dosage by varying the degree of promoter truncation can be a strong tool for optimization of productivity. The application of the URA3d-based expression systems showed a high potential for industrial protein production and for further academic studies.
KeywordsPromoter truncation URA3d LEU2d Human insulin Plasmid copy number High cell density cultivation
This work was financially supported by Novo Nordisk A/S and the Danish Ministry of Science Technology and Innovation (VTU).
Conflict of interest
The authors declare no competing interests.
- Delorme E (1989) Transformation of Saccharomyces cerevisiae by electroporation. Appl Env Microbiol 55:2242–2246Google Scholar
- Erhart E, Hollenberg CP (1983) The presence of a defective LEU2 gene on 2μ DNA recombinant plasmids of Saccharomyces cerevisiae is responsible for curing and high copy number. J Bacteriol 156:625–635Google Scholar
- Gietz RD, Woods RA (2001) Genetic transformation of yeast. Biotechniques 30:816–831Google Scholar
- Hinnebusch AG (1992) General and pathway-specific regulatory mechanisms controlling the synthesis of amino acid biosynthetic enzymes in Saccharomyces cerevisiae. In: Jones WE, Pringle JR, Broach JR (eds) The molecular and cellular biology of the yeast Saccharomyces gene expression 2. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 319–414Google Scholar
- Payne T, Finnis C, Evans L, Mead D, Avery S, Archer D, Sleep D (2008) Modulation of chaperone gene expression in mutagenized Saccharomyces cerevisiae strains developed for recombinant human albumin production results in increased production of multiple heterologous proteins. Appl Env Microbiol 74:7759–7766CrossRefGoogle Scholar
- Symington L, Brown A, Oliver SG, Greenwell P, Petes TD (1991) Genetic analysis of a meiotic recombination hotspot on chromosome III of Saccharomyces cerevisiae. Genetics 128:717–727Google Scholar